Heart disease. Diabetes also increases the risk for heart disease and narrowing of the arteries (due to atherosclerosis), both of which may contribute to cold hands and feet. Nerve damage.

Novo Nordisk has announced plans to move its ziltivekimab into phase 3 clinical development in atherosclerosis with chronic kidney disease after a mid-stage trial met its main goal. The Danish ...